hrc/iart/syk/wmgi updat estim
updat estim follow
preannounc morgan healthcar confer week
rais adjust ep estim
respect account
compani above-consensu fiscal revenu impact
tax reform minim re-invest tax save busi
also rais price target
rais adjust ep estim
reflect better-than-anticip revenu
expect slightli higher organ growth stronger base
rais adjust ep estim
reflect compani strong organ growth addit lower
adjust ep forecast compani reflect
first-year dilut acquisit entellu medic expect
close higher tax rate follow tax reform
maintain adjust ep estim
neg posit respect updat forecast
includ modest revenu out-performance compani mid-
decemb acquisit imascap sa
encourag favor calendar preannounc
cover compani week exceed
consensu revenu expect quarter group posit
hrc comment regard confid higher core busi growth
remaind year conservat guidanc centrella
launch benefit tax reform reiter buy rate
neutral rate
import pleas read disclosur disclaim page report
updat estim follow preannounc
morgan healthcar confer earlier week
januari pre-announce fiscal end decemb revenu million
consensu expect million estim million compani core
growth exclud acquisit plan complet divestitur currenc movement
quarter flat guidanc notabl busi contribut revenu upsid
rel hrc fiscal expect includ patient support system surgic solut
due better-than-anticip revenu expect exceed top end fiscal adjust ep
guidanc rang factor benefit tax reform compar
estim consensu expect compani pre-announce
expect million sale product compani launch sinc
million sale product notabl compani suggest new
product sale outlook assum rel conserv contribut launch tit centrella
medsurg hospit bed make us feel better hrc outlook given favor commentari
heard industri contact centrella prospect above-averag growth
 medsurg bed segment decemb research note detail
expect adjust effect tax rate declin bp futur period result
 tax reform moreov compani anticip vast major tax save flow
earn minim increment re-invest busi
rais adjust ep estim
respect account compani above-consensu fiscal revenu
impact tax reform minim re-invest tax save busi also rais
price target
januari report preliminari revenu approxim million versu consensu
expect million million estim quarter compani achiev
organ growth exclud discontinu product increas last quarter
impli guidanc aid faster-than-expect recoveri puerto rico
manufactur oper improv dural repair sale
expect adjust ep prior guidanc rang includ
impact tax reform compar consensu expect
estim compani pre-announce notabl still evalu tax
reform impact busi expect provid detail earn call
rais adjust ep estim
reflect better-than-anticip revenu expect slightli higher organ growth
stronger base
januari pre-announce year-over-year increas preliminari revenu
roughli million well estim million consensu expect
million quarter compani organ growth exceed
estim similar strong result medsurg equip organ versu
estim drove upsid rel forecast notabl within medsurg equip syk
expect sale headwind product suppli issu bad anticip better
compani neg million guidanc sale core medic product stretcher
hospit bed physio-control except strong second straight quarter
orthoped post organ growth similar estim led organ growth
compani knee busi forecast rang
quarter compani saw stronger contribut mako total knee applic includ new
mako system placement progress anticip total knee upgrad exist
mako custom continu traction cementless knee offer knee
sale decemb sign least modestli improv domest joint reconstruct market
expect adjust ep upper half guidanc rang versu
estim consensu expect
view tax reform modest increment neg compani whose adjust
effect tax rate expect rang manag within financi
object includ adjust ep growth least year-over-year compani expect
provid detail earn call januari
provid posit comment hospit capit spend environ evidenc
order backlog
spoke posit adjust oper margin dynam follow expect
modest year-over-year declin metric
mention spine shoulder total ankl hip arthroscopi area see signific
promis robot previous written expect introduc shoulder
ankl replac applic mako robot surgeri system research suggest
compani current target launch applic although may take
late applic enter gener releas compani conduct longer limit
launch mako total knee applic continu believ current
necessari implant fulli capit opportun robot shoulder ankl
replac think compani could address acquir
rais adjust ep estim reflect compani strong
organ growth addit lower adjust ep forecast compani
reflect first-year dilut acquisit entellu medic expect
close higher tax rate follow tax reform
corpor organ growth analysiscategorynorthcoastreportedtot compani organ orthoped medsurg equip neurotechnolog spine compani report northcoast research estim pre-announce
januari pre-announc preliminari revenu million
consensu expect million million forecast quarter organ growth
includ contribut four extra sell day year-over-year also modestli
forecast product standpoint except strong sale upper extrem
product constant currenc biolog constant currenc off-set weaker
result lower extrem constant currenc anticip
highlight sever key product launch particularli lower extrem busi
includ mi instrument launch infin biofoam total ankl replac system
launch propheci invis revis total ankl replac system launch along plan
greater avail instrument set ortholoc ankl fractur lp system gener
better-than-expect demand present overal think stronger new product year
along improv contribut sale rep addit start turn around wmgi lower
extrem sale
maintain adjust ep estim neg posit
respect updat forecast includ modest revenu out-performance
compani mid-decemb acquisit imascap sa
organ growth analysiscategorynorthcoastreportedtot compani organ upper extrem lower extrem biolog sport medicin product compani report northcoast research estim includ extra sell day yr/yr
hill-rom hold inc annual incom statement analysi adjust northcoast research million except percent per share sg interest incom incom extra margin extra com share growth ep growth compani report northcoast research estimate start exclud acquistion-rel intang amort expens adjust ep
corp annual incom statement analysi adjust northcoast research thousand except percentag per share gross gross sg intang asset sg oper oper net interest incom interest interest incom incom incom tax incom extra incom extra extra net net wghd com share ep ep growth ep growth compani report northcoast research estim exclud seaspin start
stryker corporationannu incom statement analysi adjust northcoast research million except percentag per share gross gross sg intang stock option expensesn/an/an/an/an/an/an/a oper oper net interest incom incom tax incom extra incom extra extra net net wghd com share ep ep growth ep growth start exclud acquistion-rel intang amort expens adjust ep compani report northcoast research estim
 annual forma incom statement analysi adjust northcoast research thousand except percentag per share net gross gross sg amort intang sg amort oper oper net interest expens expens incom incom tax adjust net incom continu adjust net margin continu extra item continu net incom continu incom discontinu net wghd com share adjust ep continu ep continu ep growth ep growth yr/yr n/an/an/an/asourc compani report northcoast research estim adjust ep exclud amort expens start revenu reflect salto ankl larg joint divestitur respect disclosur
